在心力衰竭中缺铁的患病率和不良结果
Habeeb Abdulkareem Habeeb1, Fraser Todd1, Rohith Valsalan2
1Department of General Medicine, Eastern Health, Melbourne.
Current cardiology reviews
|February 18, 2025
概括
缺铁 (ID) 在心力衰竭 (HF) 患者中很常见,并显著增加不良结果,主要是由于再入院率较高. 这种关联在心力衰竭与减少喷射率 (HFrEF) 中似乎比HFpEF更强.
科学领域:
- 心脏病学 心脏病学
- 内部医学 内部医学
- 血液学 血液学 血液学
背景情况:
- 铁缺乏症 (ID) 的患病率和心力衰竭 (HF) 的结果报告变化,特别是在混合HF亚型中.
- 了解ID的影响对于管理HF患者至关重要.
研究的目的:
- 确定混合HF亚型的住院患者中ID的患病率.
- 调查ID和不良结果之间的关联,包括死亡率和再录取.
主要方法:
- 在6个月内对成年HF患者进行了回顾性研究.
- 血清费里丁和转激素和水平定义的ID.
- 对于ID病例,选择了性别和年龄匹配的对照.
- 主要结局:所有原因死亡率或12个月内再入院的组合.
主要成果:
- 在131名评估的HF患者中,有45%患有ID.
- 经过调整后,ID与主要复合结果 (OR:6.04,P=0.031) 有显著的关联.
- ID独立预测了再入院 (OR:4.61,P=0.03),但没有死亡率.
- ID显示与HFrEF中的初级结果的关联比HFpEF更强.
结论:
- 在住院的HF患者中,缺铁很普遍.
- ID独立地与增加的不良结果有关,主要是由再录取驱动的.
- ID对不良结果的影响可能在HF亚型 (HFrEF与HFpEF) 之间有所不同.
相关概念视频
Pathophysiology of Heart Failure
1.5K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
371
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
371
Imbalances in Cardiac Output
1.3K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.3K
Ischemic Heart Disease: Overview
1.1K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.1K
Heart Failure Drugs: Diuretics
334
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
334
Heart Failure Drugs: Inotropic Agents
500
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
500


